Prognostic Utility of Absolute Coronary Microvascular Function by PET/CT

PET/CT 绝对冠状动脉微血管功能的预后用途

基本信息

  • 批准号:
    8267105
  • 负责人:
  • 金额:
    $ 14.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-01 至 2014-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The purpose of this proposal is to promote scientific development and investigative skills of the candidate in order that she may become an independent clinical investigator. The noninvasive cardiovascular imaging center at the Brigham and Women's Hospital provides the Ideal setting in which the candidate will study the prognostic value of coronary microvascular function, while enrolled in a Masters degree in Public Health at the Harvard School of Public Health. Through the collaboration with the clinical mentor, and highly experienced scientific advisors, the candidate will obtain a foundation for the development of an independent academic career. The link between myocardial ischemia, epicardlal coronary artery disease (CAD) and survival Is well established. More recently, coronary microvascular dysfunction has been reported in several clinical syndromes such as hypertensive heart disease, cardiomyopathy and syndrome X, In subjects without obstructive epicardlal CAD. Preliminary evidence suggests that microvascular dysfunction is associated with worse outcomes. Until recently, evaluation of coronary microvascular function has been impeded by methodological limitations, and hence, its nature and mechanisms remain speculative. Positron emission tomography (PET) represents an extremely powerful tool to assess coronary microvascular function. The central goal of this study is to determine the prognostic value of coronary microvascular function using Rubldlum-82 PET. The candidate has demonstrated the prognostic value of relative Rubldium-82 PET, reflecting severity of epicardlal CAD. In specific Aims 1-3, the candidate will study the value of coronary microvascular function to predict major adverse cardiac events of sudden death, risk of left ventricular remodeling/heart failure, and risks from progression to obstructive epicardlal CAD. We anticipate that the proposed studies outlined here will provide important mechanistic links between coronary microvascular dysfunction and cardiac events. The results of these studies will serve as a foundation to design future studies of specific therapies directed at improving coronary microvascular function and clinical outcomes. RELEVANCE (See instructions): The big coronary arteries supplying blood to the heart course on the surface and are visible by dye injection (angiography), but the vessels entering the heart muscle are very small and not seen on angiography. These microvessels play a major role in blood flow to the heart, especially during activity. The purpose of this study is to find out If microcirculatory abnormalities can predict risk of future adverse outcomes from heart disease. (End of Abstract)
描述(由申请人提供):本提案的目的是促进候选人的科学发展和调查技能,以便她成为独立的临床研究者。布里格姆妇女医院的非侵入性心血管成像中心提供了理想的环境,候选人将在哈佛公共卫生学院攻读公共卫生硕士学位时研究冠状动脉微血管功能的预后价值。通过与临床导师和经验丰富的科学顾问的合作,候选人将获得独立学术生涯发展的基础。心肌缺血、心外膜冠状动脉疾病(CAD)和生存率之间的联系已得到充分证实。最近,在一些临床综合征如高血压性心脏病、心肌病和X综合征中,在无阻塞性心外膜CAD的受试者中报告了冠状动脉微血管功能障碍。初步证据表明,微血管功能障碍与不良结局相关。直到最近,冠状动脉微血管功能的评价一直受到方法学限制的阻碍,因此,其性质和机制仍然是推测性的。正电子发射断层扫描(PET)是一个非常强大的工具,以评估冠状动脉微血管功能。本研究的中心目标是使用Rubldlum-82 PET确定冠状动脉微血管功能的预后价值。候选人已证明相对铷-82 PET的预后价值,反映心外膜CAD的严重程度。在特定目标1-3中,候选人将研究冠状动脉微血管功能的价值,以预测猝死的主要不良心脏事件、左心室重塑/心力衰竭风险以及进展为阻塞性心外膜CAD的风险。我们预计,这里概述的拟议研究将提供冠状动脉微血管功能障碍和心脏事件之间的重要机制联系。这些研究的结果将作为设计未来旨在改善冠状动脉微血管功能和临床结果的特定疗法研究的基础。相关性(参见说明):向心脏供血的大冠状动脉在表面上行进,并且通过染料注射(血管造影术)可见,但是进入心肌的血管非常小,并且在血管造影术上看不到。这些微血管在流向心脏的血液中起着重要作用,特别是在活动期间。这项研究的目的是找出微循环异常是否可以预测心脏病未来不良后果的风险。 (End摘要)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sharmila Dorbala其他文献

Sharmila Dorbala的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sharmila Dorbala', 18)}}的其他基金

Interplay of Myocardial Fibrosis and Cardiac TTR Amyloid in Age Related Cardiac Remodeling in MESA-Multi-Ethnic Study of Atherosclerosis
MESA 动脉粥样硬化多种族研究中心肌纤维化和心脏 TTR 淀粉样蛋白在年龄相关心脏重塑中的相互作用
  • 批准号:
    10467374
  • 财政年份:
    2022
  • 资助金额:
    $ 14.1万
  • 项目类别:
Interplay of Myocardial Fibrosis and Cardiac TTR Amyloid in Age Related Cardiac Remodeling in MESA-Multi-Ethnic Study of Atherosclerosis
MESA 动脉粥样硬化多种族研究中心肌纤维化和心脏 TTR 淀粉样蛋白在年龄相关心脏重塑中的相互作用
  • 批准号:
    10589058
  • 财政年份:
    2022
  • 资助金额:
    $ 14.1万
  • 项目类别:
Mentoring Patient Oriented Research in Innovative Imaging and High-dimensional Data Approaches to Improve Outcomes in Cardiac Amyloidosis
指导创新成像和高维数据方法中以患者为导向的研究,以改善心脏淀粉样变性的治疗结果
  • 批准号:
    10191887
  • 财政年份:
    2021
  • 资助金额:
    $ 14.1万
  • 项目类别:
Mentoring Patient Oriented Research in Innovative Imaging and High-dimensional Data Approaches to Improve Outcomes in Cardiac Amyloidosis
指导创新成像和高维数据方法中以患者为导向的研究,以改善心脏淀粉样变性的治疗结果
  • 批准号:
    10627775
  • 财政年份:
    2021
  • 资助金额:
    $ 14.1万
  • 项目类别:
Mentoring Patient Oriented Research in Innovative Imaging and High-dimensional Data Approaches to Improve Outcomes in Cardiac Amyloidosis
指导创新成像和高维数据方法中以患者为导向的研究,以改善心脏淀粉样变性的治疗结果
  • 批准号:
    10397096
  • 财政年份:
    2021
  • 资助金额:
    $ 14.1万
  • 项目类别:
Early Detection of Transthyretin Cardiac Amyloidosis: Defining a Novel Target for HFpEF Treatment and Prevention in Late Life
甲状腺素运载蛋白心脏淀粉样变性的早期检测:确定晚年 HFpEF 治疗和预防的新目标
  • 批准号:
    10569547
  • 财政年份:
    2020
  • 资助金额:
    $ 14.1万
  • 项目类别:
Early Detection of Transthyretin Cardiac Amyloidosis: Defining a Novel Target for HFpEF Treatment and Prevention in Late Life
甲状腺素运载蛋白心脏淀粉样变性的早期检测:确定晚年 HFpEF 治疗和预防的新目标
  • 批准号:
    10115113
  • 财政年份:
    2020
  • 资助金额:
    $ 14.1万
  • 项目类别:
Early Detection of Transthyretin Cardiac Amyloidosis: Defining a Novel Target for HFpEF Treatment and Prevention in Late Life
甲状腺素运载蛋白心脏淀粉样变性的早期检测:确定晚年 HFpEF 治疗和预防的新目标
  • 批准号:
    10333349
  • 财政年份:
    2020
  • 资助金额:
    $ 14.1万
  • 项目类别:
Molecular Imaging of Primary Amyloid Cardiomyopathy
原发性淀粉样心肌病的分子影像
  • 批准号:
    9124197
  • 财政年份:
    2016
  • 资助金额:
    $ 14.1万
  • 项目类别:
Prognostic Utility of Absolute Coronary Microvascular Function by PET/CT
PET/CT 绝对冠状动脉微血管功能的预后用途
  • 批准号:
    8080431
  • 财政年份:
    2009
  • 资助金额:
    $ 14.1万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 14.1万
  • 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
  • 批准号:
    2601817
  • 财政年份:
    2021
  • 资助金额:
    $ 14.1万
  • 项目类别:
    Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
  • 批准号:
    2029039
  • 财政年份:
    2020
  • 资助金额:
    $ 14.1万
  • 项目类别:
    Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
  • 批准号:
    9888417
  • 财政年份:
    2019
  • 资助金额:
    $ 14.1万
  • 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
  • 批准号:
    17K11318
  • 财政年份:
    2017
  • 资助金额:
    $ 14.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 14.1万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 14.1万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 14.1万
  • 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
  • 批准号:
    BB/M50306X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 14.1万
  • 项目类别:
    Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
  • 批准号:
    288272
  • 财政年份:
    2013
  • 资助金额:
    $ 14.1万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了